Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the issuance of two key US Patents related to its high-performance, exome-wide liquid biopsy platform ...

GenomOncology, an a precision medicine software company, and Genomenon, a leading genomic intelligence company, today announced a strategic partnership aimed at streamlining germline variant ...

This content includes evidence supporting variant classifications, gene-disease relationships, and various evidence automations, all aligned ... into GenomOncology's platform, we can streamline ...

Skydance Games have announced that Behemoth will be launching on PCVR this December 5, alongside all other platforms.

Zelnick explained that the upcoming open-world game is hyper-focused on providing a great experience on all available platforms. With no PC port confirmed, the game’s initial release is ...

The workflow includes organoid culture, characterization through HE staining, whole exome sequencing ... the organoids provide a valuable platform for screening drugs and exploring personalized ...

Telegram has emerged as a key development platform for Web3 games, capturing 21% of new Web3 ... “Our research aims to equip stakeholders across all chains, genres, and platforms with the ...

The game is launching for PS4, PS5, Xbox One, Xbox Series X|S, PC, and Nintendo Switch. While Sonic X Shadow Generations will be available in digital form for all platforms, only the PS4 ...

ComicBook has compiled a list of five Marvel games that are in desperate need of ports and remasters on platforms like Steam, Switch, PS5, and Xbox. 3. Marvel Ultimate Alliance– After developing ...

and here is how you can make sure your choices from the first game count. Life is Strange: Double Exposure is available on a wide range of platforms, including all major consoles. You can enjoy ...

Exome and genome volume Exome and genome test results volume grew to 19,262, an increase of 46% year-over-year and 7% sequentially. Exome and genome represented 33% of all test results ...